Literature DB >> 15634288

ABO blood group genotypes and the risk of venous thrombosis: effect of factor V Leiden.

V M Morelli, M C H De Visser, H L Vos, R M Bertina, F R Rosendaal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15634288     DOI： 10.1111/j.1538-7836.2004.01071.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  27 in total

1.  Race, ABO blood group, and venous thromboembolism risk: not black and white.

Authors:  Chunhui Fang; Hillel W Cohen; Henny H Billett
Journal:  Transfusion       Date:  2012-04-27       Impact factor: 3.157

Review 2.  Beyond immunohaematology: the role of the ABO blood group in human diseases.

Authors:  Giancarlo Maria Liumbruno; Massimo Franchini
Journal:  Blood Transfus       Date:  2013-10-03       Impact factor: 3.443

3.  ABO blood group polymorphisms and risk for ischemic stroke and peripheral arterial disease.

Authors:  Adriano de Paula Sabino; Daniel Dias Ribeiro; Caroline Pereira Domingheti; Danyelle Romana Alves Rios; Luci Maria SantAna Dusse; Maria das Graças Carvalho; Ana Paula Fernandes
Journal:  Mol Biol Rep       Date:  2014-01-22       Impact factor: 2.316

Review 4.  Inherited risk factors for venous thromboembolism.

Authors:  Ida Martinelli; Valerio De Stefano; Pier M Mannucci
Journal:  Nat Rev Cardiol       Date:  2014-01-14       Impact factor: 32.419

5.  ABO blood group related venous thrombosis risk in patients with peripherally inserted central catheters.

Authors:  Chung Mo Koo; Ravi Vissapragada; Rebecca Sharp; Phi Nguyen; Thomas Ung; Chrismin Solanki; Adrian Esterman
Journal:  Br J Radiol       Date:  2017-12-11       Impact factor: 3.039

Review 6.  Environmental and Genetic Risk Factors Associated with Venous Thromboembolism.

Authors:  Marta Crous-Bou; Laura B Harrington; Christopher Kabrhel
Journal:  Semin Thromb Hemost       Date:  2016-10-20       Impact factor: 4.180

7.  Relationship between ABO blood groups and von Willebrand factor, ADAMTS13 and factor VIII in patients undergoing hemodialysis.

Authors:  Danyelle R A Rios; Ana Paula Fernandes; Roberta C Figueiredo; Daniela A M Guimarães; Cláudia N Ferreira; Ana C Simões E Silva; Maria G Carvalho; Karina B Gomes; Luci Maria Sant' Ana Dusse
Journal:  J Thromb Thrombolysis       Date:  2012-05       Impact factor: 2.300

8.  Genetic variation within the anticoagulant, procoagulant, fibrinolytic and innate immunity pathways as risk factors for venous thromboembolism.

Authors:  J A Heit; J M Cunningham; T M Petterson; S M Armasu; D N Rider; M DE Andrade
Journal:  J Thromb Haemost       Date:  2011-06       Impact factor: 5.824

9.  ABO blood groups and genetic risk factors for thrombosis in Croatian population.

Authors:  Irena Jukic; Jasna Bingulac-Popovic; Vesna Dogic; Ivana Babic; Jelena Culej; Maja Tomicic; Tomislav Vuk; Dorotea Sarlija; Melita Balija
Journal:  Croat Med J       Date:  2009-12       Impact factor: 1.351

10.  ABO genotype and risk of thrombotic events and hemorrhagic stroke.

Authors:  K L Wiggins; N L Smith; N L Glazer; F R Rosendaal; S R Heckbert; B M Psaty; K M Rice; T Lumley
Journal:  J Thromb Haemost       Date:  2008-11-25       Impact factor: 5.824
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.